Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04246463 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Terumo Aortic Global Endovascular Registry

Study acronym: TiGER
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 44 to 58
    • Eligibility criteria shortened, about 15 words
    • Secondary endpoints: 2 to 3
    v7
  2. Study sites: 38 to 44v6
  3. Study sites: 36 to 38v5
  4. Study sites: 38 to 36
    • Secondary endpoints: details revised at 1 of 2 entries
    v4
  5. Study sites: 17 to 38v3
  6. Study sites: 6 to 17v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Vascutek Ltd.
7 trials monitored
See 1 trial at risk
Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.
Trial Details
NCT Number NCT04246463
Lead Sponsor Vascutek Ltd.
Collaborators: Bolton Medical
Conditions
(from sponsor)		 Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Related terms Aortic Aneurysm, Abdominal, Aortic Aneurysm, Thoracic
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov